Gene-edited tomatoes could be the next medicine to fight cancer and heart disease

In a potential new milestone in agricultural biotechnology, a gene-edited tomato is believed to fight cancer and heart disease. Developed in England, researchers say the deep purple tomato contains high levels of anthocyanins, which are found in berries and other fruit.

USDA has formally decided that the tomato does not warrant regulation because it is not a plant pest risk. Rabobank predicts products like this will take off in the market in the next several years.

Related:

Rabobank: Gene-edited plants will grow in the next five years

It’s all about supporting tomatoes from the “ground up”

Which “perfectly delicious” cherry tomato is right for you?






LATEST STORIES BY THIS AUTHOR:

The upcoming year holds significant importance for the Climate Smart Commodities Program, as partnerships and data reporting take center stage, according to a top USDA official.
A landmark agreement aimed at salmon restoration and clean energy projects along the Snake River is facing intense scrutiny and opposition from the agricultural industry.
Livestock producers are increasingly turning their attention to grazing management as a key strategy for optimizing production.
As spring planting nears, Midwestern farmers are gearing up for a season filled with opportunities and challenges like market pressures and pest dynamics.
The Environmental Protection Agency (EPA) has recently unveiled a new herbicide plan, sparking concerns among soybean farmers across the United States.
A recent study by the Environmental Defense Fund in Kansas is urging farmers to diversify crop portfolios to mitigate risks and ensure long-term sustainability.